May 17, 2020

Bristol Myers suspends mid-stage trial of hepatitis C drug

Global bio-pharmaceutical company
experimental hepatitis C
Admin
2 min
Bristol Myers suspends mid-stage trial of experimental hepatitis C drug
Global bio-pharmaceutical company Bristol Myers Squibb Co has suspended a mid-stage trial of an experimental hepatitis C drug it secured in its $2.5 bi...

Global bio-pharmaceutical company Bristol Myers Squibb  Co has  suspended a mid-stage trial of an experimental hepatitis C drug  it secured in its $2.5 billion buyout of Inhibitex Inc after one patient  developed heart failure.

 The New York-based drug maker said it has suspended the clinical trial of the drug known as BMS-986094 as a concern for safety.  

The drug maker has stopped the administration of the drug to about 30 patients who were a part of the Phase 2b study.  The heart failure occurred in a patient who received the highest daily dose of 200 miligrams.

Sonia Choi, a Bristol-Myers spokeswoman said, “Although the issue presented in a patient receiving that dose, it doesn’t preclude the possibility of issues with other doses.” Sonia also said, “At this point, we don’t know what the cause of the safety issue is. We are taking time to evaluate information on all patients receiving this compound.” 

The global pharma company has used acquisitions to get new experimental medicines as it aims to replace the loss of revenue from Plavix, a blood thinner which generated 33%  of 2011 sales. Bristol Myers is also competing with  other drug company Gilead Sciences Inc  to get clearance of the new generation of medicines to treat  the estimated 170 million patients with hepatitis C.

Bristol Myers Squibb is a pharmaceutical company formed through the merger of its predecessors Bristol-Myers and the Squibb Corporation. 

Share article

May 24, 2021

Schneider Electric's intelligent patient room: need to know

smarthospital
Automation
IoT
connectedhealth
2 min
We take a look at Schneider Electric's new smart patient room. 

Schneider Electric has launched a virtual showcase that features its new "intelligent patient room". What is it exactly? 

Who: Schneider Electric is a multinational that develops energy and automation solutions for many different industries - including hospitality, education, defence, and healthcare. Founded in 1836, today it is a Fortune 500 company, and it currently provides technology to 40% of hospitals around the world, among them Penn Medicine, one of the top hospitals in the US where Schneider's EcoStruxure for Healthcare is deployed, an IoT solution. 

What: Schneider has launched its Innovation Experience Live Healthcare Lab, an immersive experience that takes visitors through a demonstration of a hospital, including the doctor’s office, the operating room, and the intelligent patient room. 

The room features a digital patient footwall - a touchscreen that creates a single reference point for patients, families and healthcare providers, by incorporating care information, entertainment and environmental controls all in one place.  A separate digital patient door display has important information for healthcare staff. 

All Schneider's equipment is low-voltage, and integrated so that the patient room, clinical needs and IT are all seamlessly connected, what Schneider calls a digital “system of systems.”

Why:  Mike Sanders, Customer Projects & Services in Healthcare Innovation at Schneider Electric, explains: “The hospital of the future will need to put the patient experience at the forefront, using innovative and connected systems to provide superior in-hospital care experiences.” 

“With the shift to remote work and business brought forth by the pandemic, we knew that we needed to invest in a new virtual experience that showcases our vision for a truly integrated healthcare experience. We believe our intelligent patient room is the solution that our healthcare partners and customers have been looking for, and we’re excited to offer a way for them to experience it no matter where they are in the world.”

Where: The virtual experience was modelled after the new innovations installed at Penn Medicine in Philadelphia, the first real-world installation of Schneider Electric’s fully integrated intelligent patient room technology. It is currently being hosted at the company’s St. Louis Innovation Hub and Innovation Executive Briefing Center (IEBC) facility.  

Share article